Tempero Bio

Developer of therapeutics to treat opioid use disorders

placeOakland, California, United States calendar_todayFounded 2020 groups2 employees language temperobio.com

Innovation

1 patent family — focus: Human necessities; filing pace accelerating. Cited 12 times.

YearFilings
20231
20241
20251

Investor mix

3 investors on record; lead investors include 8VC.

Investor typeCountShare
Venture capital133%
Bank & private debt133%
Other / undisclosed133%
Coming soon